Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: Systematic review and meta-analysis of 14 015 stroke cases and pooled analysis of primary biomarker data from up to 60 883 individuals

International Journal of Epidemiology

Volumn 42, Issue 2, 2013, Pages 475-492

  Khan, Tauseef A ^a   Shah, Tina ^b   Prieto, David ^a   Zhang, Weili ^c   Price, Jackie ^d   Fowkes, Gerald R ^d   Cooper, Jackie ^b   Talmud, Philippa J ^b   Humphries, Steve E ^b   Sundstrom, Johan ^e   Hubacek, Jaroslav A ^f   Ebrahim, Shah ^a   Lawlor, Debbie A ^g   Ben Shlomo, Yoav ^g   Abdollahi, Mohammad R ^g   Slooter, Arjen J C ^h   Szolnoki, Zoltan ⁱ   Sandhu, Manjinder ^j   Wareham, Nicholas ^k   Frikke Schmidt, Ruth ^l   Tybjærg Hansen, Anne ^l   Fillenbaum, Gerda ^m   Heijmans, Bastiaan T ⁿ   Katsuya, Tomohiro ^o   Gromadzka, Grazyna ^p   Singleton, Andrew ^q   Ferrucci, Luigi ^q   Hardy, John ^r   Worrall, Bradford ^s   Rich, Stephen S ^s   Matarin, Mar ^r   Whittaker, John ^a   Gaunt, Tom R ^g   Whincup, Peter ^t   Morris, Richard ^u   Deanfield, John ^v   Donald, Ann ^v   Smith, George Davey ^g   Kivimaki, Mika ^b   Kumari, Meena ^b   Smeeth, Liam ^a   Khaw, Kay Tee ^k   Nalls, Michael ^q   Meschia, James ^w   Sun, Kai ^c   Hui, Rutai ^c   Day, Ian ^g   Hingorani, Aroon D ^b   Casas, Juan P ^a,b   more..

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c FUWAI HOSPITAL   (China)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^f INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^g UNIVERSITY OF BRISTOL   (United Kingdom)

^h UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

ⁱ Pandy County Hospital   (Hungary)

^j UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^k ADDENBROOKE S HOSPITAL   (United Kingdom)

^l Rigshospitalet   (Denmark)

^m DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^o OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^p INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^q NATIONAL INSTITUTES OF HEALTH   (United States)

^r UNIVERSITY COLLEGE LONDON   (United Kingdom)

^s UNIVERSITY OF VIRGINIA   (United States)

^t ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^u ROYAL FREE HOSPITAL   (United Kingdom)

^v UNIVERSITY COLLEGE LONDON   (United Kingdom)

^w MAYO CLINIC   (United States)

more..

Author keywords

Apolipoprotein E; Biomarkers; Cardiovascular disease; Lipids; Meta analysis; Stroke; Systematic review

Indexed keywords

APOLIPOPROTEIN E; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ANCESTRY; BIOMARKER; CARDIOVASCULAR DISEASE; DATA ACQUISITION; GENOTYPE; HEALTH RISK; META-ANALYSIS; REGRESSION ANALYSIS; STROKE;

ARTERIAL WALL THICKNESS; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LIPOPROTEIN BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTEMATIC REVIEW; TRIACYLGLYCEROL BLOOD LEVEL;

APOLIPOPROTEINS E; BIOLOGICAL MARKERS; CAROTID INTIMA-MEDIA THICKNESS; CHOLESTEROL, LDL; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LIPIDS; RISK FACTORS; STROKE; TRIGLYCERIDES;

EID: 84877040268     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyt034     Document Type: Article

References (80)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006;367:1747-57.
2. Feigin VL, Lawes CMM, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet 2003;2:43-53.
3. Lewington S, Whitlock G, Clarke R et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths. Lancet 2007;370:1829-39.
4. Baigent C, Keech A, Kearney PM et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366:1267-78.
5. Amarenco P, Steg PGG. The paradox of cholesterol and stroke. Lancet 2007;370:1803-04.
6. Mahley RW, Rall SC. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 2000;1:507-37.
7. Teslovich TM, Musunuru K, Smith AV et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010;466:707-13.
8. Aulchenko YS, Ripatti S, Lindqvist I et al. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet 2009;41:47-55.
9. Wallace C, Newhouse SJ, Braund P et al. Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet 2008;82:139-49.
10. Willer CJ, Sanna S, Jackson AU et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 2008;40:161-69.
11. Bennet AM, Di Angelantonio E, Ye Z et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 2007;298:1300-11.
12. Grönroos P, Raitakari OT, Kähönen M et al. Relation of Apolipoprotein E Polymorphism to Markers of Early Atherosclerotic Changes in Young Adults. Circulation 2008;72:29-34.
13. Rontu R, Ojala P, Hervonen A et al. Apolipoprotein E genotype is related to plasma levels of C-reactive protein and lipids and to longevity in nonagenarians. Clin Endocrinol 2006;64:265-70.
14. Berrahmoune H, Herbeth B, Siest G, Visvikis-Siest S. Heritability of serum hs-CRP concentration and 5-year changes in the Stanislas family study: association with apolipoprotein E alleles. Genes Immun 2007;8:352-59.
15. Chasman DI, Kozlowski P, Zee RY, Kwiatkowski DJ, Ridker PM. Qualitative and quantitative effects of APOE genetic variation on plasma C-reactive protein, LDLcholesterol, and apoE protein. Genes Immun 2006;7:211-19.
16. Elliott P, Chambers JC, Zhang W et al. Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 2009;302:37-48.
17. Marz W, Scharnagl H, Hoffmann MM, Boehm BO, Winkelmann BR, März W. The apolipoprotein E polymorphism is associated with circulating C-reactive protein (the Ludwigshafen risk and cardiovascular health study). Eur Heart J 2004;25:2109-19.
18. Tsoi L-M, Wong K-Y, Liu Y-M, Ho Y-Y. Apoprotein E isoform-dependent expression and secretion of pro-inflammatory cytokines TNF-alpha and IL-6 in macrophages. ArchBiochem Biophys 2007;460:33-40.
19. Sudlow C, Martínez González NA, Kim J, Clark C. Does apolipoprotein E genotype influence the risk of ischaemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage? Systematic review and meta-analyses of 31 studies among 5961 cases and 17 965 controls. Stroke 2006; 37:364-70.
20. Paternoster L, Martínez González NA, Lewis S, Sudlow C. Association between apolipoprotein E genotype and carotid intima-media thickness may suggest a specific effect on large artery atherothrombotic stroke. Stroke 2008;39:48-54.
21. Polak JF, Pencina MJ, Pencina KM et al. Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med 2011;365:213-21.
22. Bellenguez C, Bevan S, Gschwendtner A et al. Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischaemic stroke. Nat Genet 2012;44:328-33.
23. Bis JC, Kavousi M, Franceschini N et al. Meta-analysis of genome-wide association studies from the CHARGE consortium identifies common variants associated with carotid intima media thickness and plaque. Nat Genet 2011;43:940-47.
24. Marmot M, Banks J, Blundell R, Lessof C. Health, wealth and lifestyles of the older population in England: The 2002 English Longitudinal Study of Ageing. Institute for Fiscal Studies 2003; Jan:357-74.
25. Miller GJ, Bauer KA, Barzegar S et al. The effects of quality and timing of venepuncture on markers of blood coagulation in healthy middle-aged men. Thromb Haemost 1995;73:82-86.
26. Marmot M, Brunner E. Cohort Profile: the Whitehall II study. Int J Epidemiol 2005;34:251-56.
27. Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991; 20:384-92.
28. Walker M, Whincup PH, Shaper AG. The British Regional Heart Study 1975-2004. Int J Epidemiol 2004; 33:1185-92.
29. Lawlor DA, Timpson N, Ebrahim S, Day INM, Davey Smith G. The association of oestrogen receptor alpha-haplotypes with cardiovascular risk factors in the British Women's Heart and Health Study. Eur Heart J 2006;27:1597-604.
30. The Caerphilly and Speedwell Collaborative Group. Caerphilly and Speedwell collaborative heart disease studies. J Epidemiol Commun Health 1984;38:259-62.
31. Dhamrait SS, Stephens JW, Cooper JA et al. Cardiovascular risk in healthy men and markers of oxidative stress in diabetic men are associated with common variation in the gene for uncoupling protein 2. Eur Heart J 2004;25:468-75.
32. Price JF, Stewart MC, Deary IJ et al. Low dose aspirin and cognitive function in middle aged to elderly adults: randomised controlled trial. BMJ 2008;337:a1198.
33. The European Atherosclerosis Research Study (EARS): design and objectives. Int J Epidemiol 1994;23:465-71.
34. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. J Clin Epidemiol 1988;41:105-14.
35. Wohlin M, Sundström J, Lannfelt L et al. Apolipoprotein E epsilon4 genotype is independently associated with increased intima-media thickness in a recessive pattern. Lipids 2007;42:451-56.
36. Ward H, Mitrou PN, Bowman R et al. APOE genotype, lipids, and coronary heart disease risk: a prospective population study. Arch Int Med 2009;169:1424-29.
37. Beilby JP, Hunt CCJ, Palmer LJ et al. Apolipoprotein E gene polymorphisms are associated with carotid plaque formation but not with intima-media wall thickening: results from the Perth Carotid Ultrasound Disease Assessment Study (CUDAS). Stroke 2003;34:869-74.
38. Slooter AJ, Bots ML, Havekes LM et al. Apolipoprotein E and carotid artery atherosclerosis: the Rotterdam study. Stroke 2001;32:1947-52.
39. Davey Smith G, Ebrahim S. Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol 2004;33:30-42.
40. Egger M, Davey Smith G, Altman D. Systematic Reviews in Health Care: Meta-analysis in Context. Oxford: Wiley-Blackwell, 2001, p. 512.
41. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327: 557
42. Abdi H. The Bonferonni and S?idák Corrections for Multiple Comparisons. In: Salkind NJ (ed.). Encyclopedia of Measurement and Statistics. Thousand Oaks, CA: Sage, 2007, pp. 1-9.
43. Higgins JPT, Thompson SG. Controlling the risk of spurious findings from meta-regression. Stat Med 2004;23: 1663-82.
44. Knapp G, Hartung J. Improved tests for a random effects meta-regression with a single covariate. Stat Med 2003;22: 2693-710.
45. Sagoo GS, Little J, Higgins JPT. Systematic reviews of genetic association studies. Human Genome Epidemiology Network. PLoS Med 2009;6:e28.
46. Gilks W, Richardson S, Spiegelhalter D. Markov Chain Monte Carlo in Practice. Abingdon: Chapman and Hall/ CRC/Taylor and Francis, 1995.
47. Warn DE, Thompson SG, Spiegelhalter DJ. Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales. Stat Med 2002;21: 1601-23.
48. Bolla MK, Wood N, Humphries SE. Rapid determination of apolipoprotein E genotype using a heteroduplex generator. J Lipid Res 1999;40:2340-45.
49. Abdollahi MR, Guthrie PAI, Davey Smith G, Lawlor DA, Ebrahim S, Day INM. Integrated single-label liquid-phase assay of APOE codons 112 and 158 and a lipoprotein study in British women. Clin Chem 2006;52: 1420-23.
50. van Vliet P, Mooijaart SP, de Craen AJM, Rensen PCN, van Heemst D, Westendorp RGJ. Plasma levels of apolipoprotein E and risk of stroke in old age. Ann NY Acad Sci 2007;1100:140-47.
51. Zhu L, Fratiglioni L, Guo Z et al. Incidence of dementia in relation to stroke and the apolipoprotein E epsilon4 allele in the very old. Findings from a population-based longitudinal study. Stroke 2000;31:53-60.
52. Haan MN, Mungas DM, Gonzalez HM, Ortiz TA, Acharya A, Jagust WJ. Prevalence of dementia in older latinos: the influence of type 2 diabetes mellitus, stroke and genetic factors. J Am Ger Soc 2003;51:169-77.
53. Fillenbaum GG, Blazer DG, Burchett BM, Saunders AM, Taylor DH. Apolipoprotein E epsilon4 and risk of mortality in African American and white older community residents. The Gerontologist 2002;42:381-86.
54. Lawlor D, Bedford C, Taylor M, Ebrahim S. Geographical variation in cardiovascular disease, risk factors, and their control in older women: British Women's Heart and Health Study. J Epidemiol Community Health 2003;57: 134-40.
55. Cholesterol Treatment Trialists' Ctt Collaborators. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 2012; 6736:1-10.
56. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31:545-48.
57. Crook R, Hardy J, Duff K. Single-day apolipoprotein E genotyping. J Neurosci Methods 1994;53:125-27.
58. Appel E, Eisenberg S, Roitelman J. Improved PCR amplification/ Hhal restriction for unambiguous determination of apolipoprotein E alleles. Clin Chem 1995;41:187-90.
59. Ebrahim S, Sung J, Song Y-M, Ferrer RL, Lawlor DA, Davey Smith G. Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study. BMJ 2006; 333:22.
60. Mahley RW, Weisgraber KH, Huang Y. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci U S A 2006;103:5644-51.
61. Drenos F, Talmud PJ, Casas JP et al. Integrated associations of genotypes with multiple blood biomarkers linked to coronary heart disease risk. Hum Mol Genet 2009;18:2305-16.
62. Lawlor DA, Davey Smith G, Harbord R, Timpson N, Day I, Ebrahim S. Clustered environments and randomized genes: a fundamental distinction between conventional and genetic epidemiology. PLoS Med 2007;4:e352.
63. Talmud P, Drenos F, Shah S et al. Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. Am J Hum Genet 2009;85: 628-42.
64. Kathiresan S, Melander O, Guiducci C et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 2008;40:189-97.
65. Kathiresan S, Willer CJ, Peloso GM et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 2009;41:56-65.
66. Roses AD, Lutz MW, Amrine-Madsen H et al. A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease. Pharmacogenomics J 2010; 10:375-84.
67. Abraham R, Moskvina V, Sims R et al. A genome-wide association study for late-onset Alzheimer's disease using DNA pooling. BMC Med Genomics 2008;1:44.
68. Klos K, Shimmin L, Ballantyne C et al. APOE/C1/C4/C2 hepatic control region polymorphism influences plasma apoE and LDL cholesterol levels. Hum Mol Genet 2008; 17:2039-46.
69. Stenga°rd JH, Frikke-Schmidt R, Tybjaerg-Hansen A, Nordestgaard BG, Sing CF. Variation in 5' promoter region of the APOE gene contributes to predicting ischaemic heart disease (IHD) in the population at large: the Copenhagen City Heart Study. Ann Hum Genet 2007;71: 762-71.
70. Stenga°rd JH, Clark AG, Weiss KM et al. Contributions of 18 additional DNA sequence variations in the gene encoding apolipoprotein E to explaining variation in quantitative measures of lipid metabolism. Am J Hum Genet 2002; 71(3):501-17.t.
71. Mahley R. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988;240: 622-30.
72. van den Maagdenberg AM, Weng W, de Bruijn IH et al. Characterization of five new mutants in the carboxylterminal domain of human apolipoprotein E: no cosegregation with severe hyperlipidemia. Am J Hum Genet 1993; 52:937-46.
73. Mailly F, Xu CF, Xhignesse M et al. Characterization of a new apolipoprotein E5 variant detected in two French-Canadian subjects. J Lipid Res 1991;32:613-20.
74. Wellcome Trust Case Control Consortium. Genome-wide association study of 14 000 cases of seven common diseases and 3 000 shared controls. Nature 2007;447: 661-78.
75. C Reactive Protein Coronary Heart Disease Genetics Collaboration. Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ 2011;342:d548.
76. Amarenco P, Labreuche J, Lavallée P, Touboul P-J. Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke 2004;35: 2902-09.
77. Amato M, Montorsi P, Ravani A et al. Carotid intimamedia thickness by B-mode ultrasound as surrogate of coronary atherosclerosis: correlation with quantitative coronary angiography and coronary intravascular ultrasound findings. Eur Heart J 2007;28:2094-101.
78. de Groot E, Hovingh GK, Wiegman A et al. Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation 2004;109(Suppl. 1):III33-38.
79. Paternoster L, Martinez-Gonzalez NA, Charleton R, Chung M, Lewis S, Sudlow CLM. Genetic effects on carotid intima-media thickness: systematic assessment and meta-analyses of candidate gene polymorphisms studied in more than 5000 subjects. Circulation. Cardiovascular genetics 2010;3:15-21.
80. Voight BF, Peloso GM, Orho-Melander M et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 2012;380: 572-80.